KCNJ2, part of the classical inward rectifying potassium channel subfamily, facilitates inward rectifying potassium currents in diverse cell types such as neurons, skeletal muscle cells, cardiac myocytes, immune cells, and cancer cells [16, 17]. The gene discussed is KCNJ2; the disease is cancer.